Peroxisome proliferator-activated receptor-gamma (PPAR-γ) agonists are insulin-sensitising drugs designed for diabetes patients with insulin resistance; furthermore, they can regulate several cellular processes, such as Aβ degradation and the anti-inflammatory response [10,11]. Here, PPARG is linked to Insulin resistance.